Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Integrated Oncology ...

Bowers added that to increase access to the latest drugs, the "cancer system" must be organized in such a way as to ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

The 39th AROI conference at CMC Vellore focused on advancements in radiation oncology with a green initiative.

The transaction, subject to regulatory approval, is expected to close later this year, a Cardinal spokesperson said.

Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Growing momentum in research sets China up as a formidable player in future of global healthcare, according to scientific ...

AVEO Oncology, an LG Chem company ("AVEO"), announced today that the TiNivo-2 Phase 3 clinical trial results in patients with ...